Quanta BioDesign

Quanta BioDesign, Ltd., is located in Powell, Ohio, a suburb of Columbus, the home of The Ohio State University. Founded in 1997 by Paul D. Davis, Ph.D. under the name BioOrganic Technologies, LLC, he moved into the company's original and current location in March of 1998. In Spring of 1999, the company changed the company's name to Quanta BioDesig... n, Ltd., in order to better reflect the company's company mission. Quanta BioDesign was founded for the purpose of developing and commercializing an extensive line of products for companies involved in drug discovery and diagnostic development programs. These products are based on the company's proprietary discrete polyethylene glycol (dPEG ®) chemistries, including the company's unique processes for making these important compounds. The company's single molecular weight ethylene glycol conjugation technology, dPEG ®, can eliminate common problems found in the development of diagnostic and therapeutic products, such as aggregation and non-specific interactions, poor water solubility, poor delivery, delivery issues/options, short serum half life, toxicity and antigenicity. The dPEG ® product line is a unique technology platform which can be custom tailored to meet specific physical, chemical and morphological requirements in a broad array of diagnostic and therapeutic applications. Chemistry applications which incorporate dPEG ® products include conjugations, simple chemical modifications, cross linking, biotinylation, signal amplification, modification of biological therapeutics and peptide synthesis. Recently the company introduced dPEG ® products that offer new delivery options as well. The company is involved in developing new cross-linking and labeling chemistries that incorporate the dPEG ® technology, and will allow for completely new approaches to existing opportunities in these same areas of therapeutic and diagnostic development, and will revolutionize many of these areas as the new generations of drugs and diagnostics evolve.Read More